Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Royal Philips (Koninklijke Philips N.V., NYSE: PHG) is a health technology company whose news flow centers on diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics and personal health. Company announcements frequently highlight AI-enabled systems, new product launches and strategic portfolio moves, giving investors and observers insight into how Philips develops and positions its health technology offerings.
Recent Philips news has featured AI-powered innovations in image-guided therapy and diagnostic imaging, such as LumiGuide 3D Device Guidance for light-based navigation during minimally invasive procedures, DeviceGuide for AI-assisted tracking of heart valve repair devices, and Verida, a detector-based spectral CT system with AI integrated across the imaging chain. The company also reports advances in MRI through its BlueSeal Horizon 3.0T platform and extended partnerships in neuroimaging, such as the integration of Cortechs.ai quantitative analytics into Philips MR workflows.
News items also cover enterprise informatics and cloud-based solutions, including the launch of Philips Management 15, a web-based diagnostic viewer that delivers full radiology capabilities through a browser and interfaces with AI tools and interactive reporting. In addition, Philips communicates on long-term partnerships with health systems, monitoring agreements and large-scale deployments of its Azurion image-guided therapy systems.
Corporate and portfolio developments appear regularly in the news stream. Examples include the agreement to acquire SpectraWAVE Inc. to expand intravascular imaging and physiology solutions, and the completed carve-out of the Philips Emergency Care business, which now operates as Heartstream under a Philips brand license. Earnings-related releases and Form 6-K summaries provide context on comparable order intake, sales trends, margins, productivity programs and outlook.
Investors and healthcare professionals following PHG news can use this page to track product introductions, AI and imaging milestones, strategic transactions and quarterly performance updates that shape Philips’ role in global health technology.
On March 25, 2021, Royal Philips (NYSE: PHG) announced the sale of its Domestic Appliances business to Hillhouse Capital for an enterprise value of approximately EUR 3.7 billion. Philips expects to receive around EUR 3 billion in cash proceeds after tax and transaction costs. Additionally, a 15-year brand license agreement will yield an estimated net present value of EUR 0.7 billion, leading to a total deal value of approximately EUR 4.4 billion. This business will be listed as a discontinued operation in Philips' financial statements starting Q1 2021.
Royal Philips (NYSE: PHG) has announced its 2021 Annual General Meeting of Shareholders (AGM) to be held on May 6, 2021. Key agenda items include the reappointment of Mr. Marnix van Ginneken and the appointment of Mrs. Chua Sock Koong and Mrs. Indra Nooyi to the Board. Shareholders can vote and follow the meeting via webcast due to COVID-19 safety measures. The full agenda and the Annual Report 2020 are available on Philips’ website.
Royal Philips, American College of Cardiology (ACC), and MedAxiom have announced a collaboration aimed at improving cardiovascular care. This partnership seeks to enhance clinical outcomes and operational efficiency by integrating guidelines and actionable data across various healthcare stakeholders. Cardiovascular disease, a leading global health challenge, is expected to incur direct medical costs of $749 billion by 2035 in the U.S. The collaboration will utilize Philips' expertise and ACC's extensive resources to address these challenges and improve overall patient care.
Summary not available.
On March 9, 2021, Royal Philips announced a partnership with openDoctor to enhance its Patient Management Solution by integrating real-time online appointment scheduling. This customized solution aims to minimize appointment no-shows, enhance scheduling convenience, and improve patient satisfaction. Philips' platform has shown significant efficiency improvements, including a 30% rise in referral conversions and a 45% reduction in no-shows. The collaboration seeks to modernize patient engagement processes, benefiting both healthcare providers and patients amidst rising interest in digital health solutions.
Philips Avent launched the Double Electric Breast Pump, Advanced, featuring innovative Natural Motion Technology that simulates a baby's suckling for quicker milk flow. The pump's compact design accommodates busy mothers, offering hands-free use with a rechargeable battery and travel bag for portability. It includes 8 stimulation and 16 expression levels, with a memory function for personalized settings. Priced at $269.99, it is available on Philips.com with widespread retail availability forthcoming.
Royal Philips (NYSE: PHG) has launched the AI-enabled Precise Suite on its Incisive CT platform to enhance CT workflows. This suite integrates features like AI-driven image reconstruction and automated patient positioning, aiming to improve image quality and operational efficiency. It addresses challenges faced by radiology departments, such as rising patient volumes and operational costs. The suite is designed to boost diagnostic confidence, reduce the need for re-scans, and streamline interventional procedures, making it a significant advancement in health technology.
Royal Philips (NYSE: PHG) has announced a significant partnership with AI software provider Lunit to integrate its INSIGHT CXR chest detection suite into Philips’ diagnostic X-ray suite. This collaboration aims to enhance workflows and patient care through AI-enabled solutions presented at the European Congress of Radiology (ECR) 2021. Additionally, Philips' Digital Radiography and Fluoroscopy system (CombiDiagnost R90) has received FDA 510(k) clearance, improving cost-effective utilization in imaging departments. This comprehensive strategy reinforces Philips’ commitment to precision diagnosis and AI integration in healthcare.
On March 3, 2021, Royal Philips (NYSE: PHG) and The Walt Disney Company EMEA announced a collaboration to enhance pediatric MRI experiences. They will pilot the Philips Ambient Experience in six European hospitals, integrating custom Disney animations to alleviate children's anxiety during procedures. This first-of-its-kind clinical research aims to improve patient experiences and operational efficiency in MRI scanning by utilizing Disney's storytelling to create a relaxing atmosphere. The pilot will begin in summer 2021 with results expected later this year.
Royal Philips (NYSE: PHG) has partnered with The Walt Disney Company to launch a groundbreaking clinical research pilot program aimed at enhancing children's experiences during MRI exams. This innovative study, commencing in six European hospitals, will utilize custom-made animated stories featuring beloved Disney characters to reduce anxiety and improve patient comfort. The Philips Ambient Experience solution integrates technology and design to create a soothing environment, empowering young patients during medical procedures. Results from the study are anticipated later in the year.